ITPR3 and neoplasm: In highly developed tumors and related stem cells, autophagy induction contradictorily promotes survival from chemotherapeutic (such as 5-FU or bortezomib) assault; competition between a plethora of tumor suppressors and promoters or oncoproteins to interact with IP3R is consistent with the above-stated observation [429,430,431].